Recombinant Human Fumarylacetoacetase/FAH Protein (His Tag)
Product Specifications
Background
Fumarylacetoacetase belongs to the FAH family. Fumarylacetoacetase is primary expressed in liver and kidney. It exists as a homodimer and catalyzes the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. Defects in Fumarylacetoacetase cause tyrosinemia type 1, which is congenital metabolism defect characterized by elevated levels of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include renal tubular injury, self-mutilation, hepatic necrosis, episodic weakness, and seizures.
Abbreviation
Fumarylacetoacetase; FAH
Synonyms
Beta-Diketonase; FAA; FAH; Fumarylacetoacetase; Fumarylacetoacetate Hydrolase
UniProt
P16930
Accession Number
P16930
Expression System
HEK293 Cells
Tag
C-His
Sequence
Ser2-Ser419
Field of Research
Signal Transduction; Cancer; metabolism
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Purity
> 95 % as determined by reducing SDS-PAGE.
Bioactivity
Not validated for activity
Reconstitution
Please refer to the printed manual for detailed information.
Shipping Conditions
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Calculated Molecular Weight
47.4 kDa
Observed Molecular Weight
43 kDa
Species
Human
Available Sizes
Documents
More Discoveries
Explore Other Products
Browse additional items from our catalog